eFoodSafety To Attend International Conference On Avian Influenza

Main Category: Bird Flu / Avian Flu
Also Included In: Conferences
Article Date: 24 Jan 2008 - 2:00 PDT

email to a friend   printer friendly   opinions  

eFoodSafety.com, Inc.'s (OTCBB: EFSF) representatives will attend the Bangkok International Conference on Avian Influenza 2008, Integration from Knowledge to Control in Bangkok from January 23-25. The conference, organized by the National Center for Genetic Engineering and Biotechnology (BIOTEC), the National Science and Technology Development Agency (NSTDA), and other related organizations, aims to provide an international forum for scientific experts and scientists to discuss avian influenza (bird flu) and to facilitate international collaboration to mitigate threats from this disease.

eFoodSafety's CitroxinTM is currently undergoing testing at Chulalongkorn University, Thailand, on a chick embryo model, for the product's ability to safely and effectively eradicate the most virulent form of the bird flu, the H5N1 virus. Chulalongkorn University is one of only a few labs in Asia used by the U.S. Centers of Disease Control to conduct research on treatments of H5N1.

"We are looking forward to attending and participating in this important conference, which addresses such a pertinent health concern not only as it applies to the general population, but also as is applies to eFoodSafety," says Timothy Matula, Director and Corporate Secretary of eFoodSafety. "This is an opportune time to meet with industry experts and share ideas about how to tackle this harmful disease."

About eFoodSafety.com

eFoodsafety.com, Inc., based in Scottsdale, Arizona, is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin™ (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The OraPhyte™ product, which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture, is currently at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

The company's Cinnergen™ is a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism, is available for sale at (http://www.cinnergen.com) and through national retailers; its Cinnechol™ is a multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system.

The company's iBoost, Inc. subsidiary is the distributor of the Immune Boost Bar™, a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body's immune system. The product contains Citroxin™, eFoodSafety's proprietary all natural supplement proven effective in fighting several types of harmful bacteria, and forty active compounds that assist with enhancing immunity, detoxification, cleansing, and metabolic efficiency. The Immune Boost Bar™ is available in three delicious flavors: chocolate, oatmeal-raisin, mint and peanut butter and can be purchased at http://www.immuneboost.com.

The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the owner of the Talsyn™-CI/bid Scar Cream, a product that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (http://www.talsyn.com), as well as seven (7) other products in the Talsyn™ line.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects" and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

http://www.efoodsafety.com

• Additional
• References
• Citations